首页> 外文期刊>Turkish Journal of Endocrinology and Metabolism >The Relation Between Epicardial Fat Tissue and TSH Receptor Antibody in Hyperthyroidism
【24h】

The Relation Between Epicardial Fat Tissue and TSH Receptor Antibody in Hyperthyroidism

机译:甲亢患者心外膜脂肪组织与TSH受体抗体的关系

获取原文
           

摘要

The pathogenesis of association between hyperthyroidism and atherosclerosis is not well known. TSH receptor antibody (TRAb) is responsible for increased fat tissue in graves ophthalmopathy. Epicardial fat tissue thickness (EFT) has been shown to increase in case of overt hyperthyroidism. In our study, we aimed to investigate the relationship between EFT and TRAb in newly diagnosed hyperthyroidism. Twenty six TRAb positive (group 1), 26 TRAb negative (due to thyroiditis, toxic adenoma or gravese) (group 2) newly diagnosed patients in outpatient clinic of Harran University were enrolled. EFT was measured by the same cradiologist using an echocardiography device. Serum TRAb levelss were measured by the ‘Radio Receptor Assay’ method and levels above 1.75 IU/L were considered as positive. There was no difference between groups in terms of age, gender and body mass index. Although there was no significant difference between group 1 and 2, mean EFT was significantly higher in groups 1 (0.38±0.15 cm) and 2 (0.4±0.17 cm) compared to group 3 (0.25±0.06 cm) (p=0.003 between group 1 and 3. p=0.001 between group 2 and 3). Furthermore. there was no significant correlation between TRAb levels and EFT. Several studies showed that hyperthyroidism has been associated with cardiovascular disease and mortality. Also the EFT has been found to be related with cardiovascular disease and mortality. TSH receptors and proteins have detected in orbital fibroblasts and adipose tissues and TSH receptors have been found to be associated with adipogenesis in Graves ophthalmopathy. Stimulation of endogenous adipogenesis in orbital preadipocytes with dealing of TRAb has been showed. The results of our study suggest that increase in EFT independent the presence of TRAb, it directly depends on the cardiovascular effects of hyperthyroidism. The change EFT with the correction of hyperthyroidism by treatment mus t be investigated.
机译:甲状腺功能亢进症与动脉粥样硬化之间的关联的发病机理尚不清楚。 TSH受体抗体(TRAb)导致严重眼病中的脂肪组织增加。在明显的甲状腺功能亢进症中,心外膜脂肪组织厚度(EFT)已显示增加。在我们的研究中,我们旨在研究新诊断的甲状腺功能亢进症中EFT和TRAb之间的关系。在哈兰大学门诊就诊的新诊断患者为26例TRAb阳性(第1组),26例TRAb阴性(归因于甲状腺炎,中毒性腺瘤或脓肿)(第2组)。由同一位放射科医生使用超声心动图仪测量EFT。血清TRAb水平通过“放射受体测定”方法测量,高于1.75 IU / L的水平被认为是阳性。年龄,性别和体重指数在两组之间没有差异。尽管第1组和第2组之间无显着差异,但第1组(0.38±0.15 cm)和第2组(0.4±0.17 cm)的平均EFT明显高于第3组(0.25±0.06 cm)(p = 0.003) 1和3。在第2组和第3组之间,p = 0.001)。此外。 TRAb水平与EFT之间无显着相关性。多项研究表明,甲状腺功能亢进症与心血管疾病和死亡率有关。还发现EFT与心血管疾病和死亡率有关。在眼眶成纤维细胞和脂肪组织中已检测到TSH受体和蛋白质,并且已发现TSH受体与Graves眼病的脂肪形成有关。已经显示通过处理TRAb刺激眼眶前脂肪细胞内源性脂肪形成。我们的研究结果表明,EFT的增加与TRAb的存在无关,它直接取决于甲亢的心血管作用。应研究通过治疗纠正甲亢的EFT变化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号